COSM vs PHVS

Analysts rate Pharvaris N.

V. (PHVS) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Pharvaris N.

V. (PHVS) delivered a total return of +31. 2%, compared to -94. 5% for Cosmos Health Inc. (COSM). Over 10 years, the gap is even starker: COSM returned +37. 8% versus PHVS's +2. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Pharvaris N.

V. (PHVS) is the lower-risk stock at 1. 02β versus Cosmos Health Inc. 's 1. 72β — meaning COSM is approximately 69% more volatile than PHVS relative to the S&P 500. On balance sheet safety, Pharvaris N. V. (PHVS) carries a lower debt/equity ratio of 0% versus 48% for Cosmos Health Inc. — giving it more financial flexibility in a downturn.

On earnings-per-share growth, the picture is similar: Cosmos Health Inc.

grew EPS 45. 6% year-over-year, compared to 5. 7% for Pharvaris N. V.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Pharvaris N.

V. (PHVS) is the more profitable company, earning 0. 0% net margin versus -29. 7% for Cosmos Health Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PHVS leads at 0. 0% versus -28. 6% for COSM. At the gross margin level — before operating expenses — COSM leads at 7. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, COSM (92.

4% yield) pays a dividend. PHVS does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Pharvaris N.

V. (PHVS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02)). Cosmos Health Inc. (COSM) carries a higher beta of 1. 72 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PHVS: +2. 3%, COSM: +37. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: COSM is a small-cap income-oriented stock; PHVS is a small-cap quality compounder stock. COSM pays a dividend while PHVS does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.